AIDS and leishmaniasis

Sexually Transmitted Infections

Volumn 73, Issue 4, 1997, Pages 237-239

  Davidson, Robert N ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY; GAMMA INTERFERON; ITRACONAZOLE; MEGLUMINE ANTIMONATE; PENTAMIDINE; STIBOGLUCONATE SODIUM;

CLINICAL FEATURE; COMORBIDITY; DISEASE COURSE; DISEASE TRANSMISSION; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERAMYLASEMIA; INTRAVENOUS DRUG ABUSE; LEISHMANIASIS; OPPORTUNISTIC INFECTION; PANCREATITIS; PRIORITY JOURNAL; VISCERAL LEISHMANIASIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIPROTOZOAL AGENTS; HUMANS; LEISHMANIASIS, VISCERAL;

EID: 79959920311     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sti.73.4.237     Document Type: Editorial

References (16)

1. Gradoni L, Scalone A, Gramiccia M, Troiani M. Epidemiological surveillance of leishmaniasis in HIV-1 infected individuals in Italy. AIDS 1996;10:785-91.
2. Alvar J, Gutierrez Solar B, Pachon I, Calbacho E, Ramirez M, Valles R, et al AIDS and Leishmania infantum. New approaches for a new epidemiological problem. Clinics in Dermatology 1996;14:541-6.
3. Bogdan C, Gessner A, Solbach A, Rollinghoff M. Invasion, control, and persistence of Leishmania parasites. Curr Opin Immunol 1996;8:517-25. (Pubitemid 26280781)
4. Leishmania/HIV co-infection: Report on the consultative meeting, Rome, 6-7 September 1994. WHO/LEISH/95-35. Geneva: World Health Organisation.
5. Miralles P, Moreno S, Perez-Tascon M, Cosin J, Diaz MD, Bouza E. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis 1995;20:872-5.
6. Carbonell Biot C, Ena Munoz J, Pasquau Liano F, Badia Ferrando P, Ortiz de Salazar Martin A, Vilar Zanon A. Fever of unknown origin in patients infected with the human immunodeficiency virus. Rev Clin Esp 1996;196:4-8. (Pubitemid 126554859)
7. Bissuel F, Leport C, Perronne C, Longuet P, Vilde JL. Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J Intern Med 1994;236:529-35. (Pubitemid 24340010)
8. Medrano FJ, Hernandez Quero J, Jimenez E, Pineda JA, Rivero A, Sanchez Quijano A, et al. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS 1992;6:1499-503.
9. Russo R, Nigro LC, Minniti S, Montineri A, Gradoni L, Caldeira L, et al. Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome). J Infect 1996;32:133-7. (Pubitemid 26131694)
10. de Gorgolas M, Castrillo JM, Fernandez Guerrero ML. Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma. Clin Infect Dis 1993;17:56-8. (Pubitemid 23197565)
11. Lortholary O, Mechali D, Christiaens D, Gougerot Pocidalo M, Brandely M, Babinet P. Interferon-γ associated with conventional therapy for recurrent visceral leishmaniasis in a patient with AIDS. Rev Infect Dis 1990;12:370.
12. Davidson RN, Di Martino L, Gradoni L, Giacchino R, Russo R, Gaeta GB, et al. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Q J Med 1994;87:75-81. (Pubitemid 24044213)
13. Torre Cisneros J, Villanueva JL, Kindelan JM, Jurado R, Sanchez Guijo P. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus. Clin Infect Dis 1993;17:625-7. (Pubitemid 23293369)
14. Gradoni L, Davidson RN, Orsini S, Betto P, Gambenedetti M. Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice. J Drug Targeting 1993;1:311-6.
15. McBride MO, Linney M, Davidson RN, Weber JN. Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconate. Clin Infect Dis 1995;21:710.
16. Ribera E, Ocana I, de Otero J, Cortes E, Gasser I, Pahissa A. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. Am J Med 1996;100:496-501.